CN113057324A - 提高免疫力、降低三高、润肠通便的养生保健膏 - Google Patents
提高免疫力、降低三高、润肠通便的养生保健膏 Download PDFInfo
- Publication number
- CN113057324A CN113057324A CN202110432882.9A CN202110432882A CN113057324A CN 113057324 A CN113057324 A CN 113057324A CN 202110432882 A CN202110432882 A CN 202110432882A CN 113057324 A CN113057324 A CN 113057324A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- rice
- raw materials
- high blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 32
- 239000008280 blood Substances 0.000 title claims abstract description 32
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 16
- 230000036039 immunity Effects 0.000 title claims abstract description 16
- 230000002040 relaxant effect Effects 0.000 title claims abstract description 14
- 150000002632 lipids Chemical class 0.000 title description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 58
- 235000009566 rice Nutrition 0.000 claims abstract description 58
- 244000068988 Glycine max Species 0.000 claims abstract description 29
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 29
- 235000021419 vinegar Nutrition 0.000 claims abstract description 29
- 239000000052 vinegar Substances 0.000 claims abstract description 29
- 235000019714 Triticale Nutrition 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 241000228158 x Triticosecale Species 0.000 claims abstract description 28
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims abstract description 26
- 240000006394 Sorghum bicolor Species 0.000 claims abstract description 25
- 240000004713 Pisum sativum Species 0.000 claims abstract description 24
- 235000010582 Pisum sativum Nutrition 0.000 claims abstract description 24
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 23
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 23
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 20
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 20
- 235000013305 food Nutrition 0.000 claims abstract description 20
- 239000010903 husk Substances 0.000 claims abstract description 19
- 208000031226 Hyperlipidaemia Diseases 0.000 claims abstract description 7
- 201000001421 hyperglycemia Diseases 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 22
- 230000036541 health Effects 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 238000010411 cooking Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 241000209094 Oryza Species 0.000 claims 14
- 238000002360 preparation method Methods 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 abstract description 44
- 230000000694 effects Effects 0.000 abstract description 30
- 230000006870 function Effects 0.000 abstract description 11
- 238000002560 therapeutic procedure Methods 0.000 abstract description 11
- 241000282414 Homo sapiens Species 0.000 abstract description 9
- 230000036772 blood pressure Effects 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 230000003750 conditioning effect Effects 0.000 abstract description 3
- 210000001835 viscera Anatomy 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 25
- 239000000047 product Substances 0.000 description 19
- 238000005728 strengthening Methods 0.000 description 12
- 235000012000 cholesterol Nutrition 0.000 description 11
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000012895 Gastric disease Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 235000017784 Mespilus germanica Nutrition 0.000 description 2
- 244000182216 Mimusops elengi Species 0.000 description 2
- 235000000560 Mimusops elengi Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 235000007837 Vangueria infausta Nutrition 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 201000003152 motion sickness Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 235000021395 porridge Nutrition 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000804384 Cynomorium songaricum Species 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 108010057186 Insulin Glargine Proteins 0.000 description 1
- COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 241000209072 Sorghum Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000019007 dietary guidelines Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 230000002892 effect on hypertension Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229960002869 insulin glargine Drugs 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000008216 juvenile development Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000030363 nerve development Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 235000012780 rye bread Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Agronomy & Crop Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
提高免疫力、降低三高、润肠通便的养生保健膏是食疗食品领域，它以达到降低血糖血压，减少血脂粘稠度，调理脏腑功能，润肠通便、增强人体免疫功能的目的，并且合理的确定各原料的使用配比，使得各原料药之间产生一定的协同作用，使产品的效果最优化，本发明包括由以下重量份的原料制备而成：高梁米0.1～1.0份、豌豆0.01～0.05份、苦荞米0.05～0.1份、大麦仁0.01～0.05份、麸皮0.01～0.05份、水10‑30份、陈醋25～40份、黄豆50～70份、黑小麦5～15份、谷壳5‑15份。
Description
技术领域
本发明涉及食疗食品领域，尤其是涉及提高免疫力、降低三高、润肠通便的养生保健膏。
背景技术
食疗是中国人的传统习惯，通过饮食达到调理身体，强壮体魄的目的。食疗文化源远流长，食疗是一种长远的养生行为。以前的人通过食疗调理身体，现在的人们通过食疗减肥、护肤、护发。
食疗是一种健康的健体之道。现有技术中有很多食疗养生组合的记载，如专利申请号201010200869公开了一种补肾强身的中药组合物，具体包括中药原料为壮阳果，枸杞，锁阳等多种的组合物。专利申请公开了一种益肾壮骨保健药酒，具体特征包括在酒基中加入了白芍、枸杞、人参等药材，以浸出相关药物的功能成分，从而实现相关的保健功能。
现有技术的缺陷在于1、用药复杂，正所谓是药三分毒，多种材料的混用通常会对最终的产品安全性等问题提出挑战。2、多种原料药使用导致了原料某些原有功效抵消或者降低，并不能实现所谓的功能，或效能不显著。
发明内容
本发明的目的是通过比较简单的原料组合提供了提高免疫力、降低三高、润肠通便的养生保健膏，以达到降低血糖血压，减少血脂粘稠度，调理脏腑功能，润肠通便、增强人体免疫功能的目的，并且合理的确定各原料的使用配比，使得各原料药之间产生一定的协同作用，使产品的效果最优化，本发明是通过以下技术方案实现的：本发明包括由以下重量份的原料制备而成：高梁米0.1～1.0份、豌豆0.01～0.05份、苦荞米0.05～0.1份、大麦仁0.01～0.05份、麸皮0.01～0.05份、水10-30份、陈醋25～40份、黄豆50～70份、黑小麦5～15份、谷壳5-15份。
本发明包括由以下重量份的原料制备而成：高粱米0.5～1.0份、豌豆0.01～0.03份、苦荞米0.075～0.1份、大麦仁0.04～0.05份、麸皮0.01～0.03份、水15-25份、陈醋35～40份、黄豆50～65份、黑小麦8～12份、谷壳8-12份。
本发明包括由以下重量份的原料制备而成：高粱米0.1～0.5份、豌豆0.03～0.05份、苦荞0.05～0.075份、大麦仁0.01～0.04份、麸皮0.03～0.05份、水20份、陈醋25～35份、黄豆65～70份、黑小麦10份、谷壳10份。
本发明包括由以下重量份的原料制备而成：包括由以下重量份的原料制备而成：高粱米0.5份、豌豆0.03份、苦荞米0.075份、大麦仁0.04份、麸皮0.03份、水20份、陈醋35份、黄豆65份、黑小麦10份、谷壳10份。
本发明包括由以下重量份的原料制备而成：包括由以下重量份的原料制备而成：高粱米0.35份、豌豆0.04份、苦荞米0.06份、大麦仁0.03份、麸皮0.03份、水20份、陈醋30份、黄豆60份、黑小麦10份、谷壳10份。
本发明安装如下步骤进行：按照上述配方称取高粱米、豌豆、大麦仁、麸皮、黑小麦、谷壳和水，具体是先将所述高粱米、豌豆、大麦仁、麸皮、黑小麦、谷壳浸泡在水中25～30min,然后加热蒸煮，沸水条件下蒸煮30～60min得到混合物；按照上述配方称取，然后将苦荞米和黄豆混合在一起，按照普通的磨粉工艺加工成含水量为2～13%、细度为80～200目的细粉；按照上述配方称取陈醋，步骤（1）得到的混合物和步骤（2）得到的细粉混合侵泡在陈醋中，密闭条件下浸泡12～24小时得到产品。
本发明与现有技术相比的有益效果在于：植物化学物质具有多种生理功能，主要表现在抗氧化作用、调节免疫力、抑制肿瘤、抗感染、降低胆固醇、延缓衰老等；具有保护人体健康和预防诸如心血管疾病和癌症等慢性疾病的作用，广泛用于保健食品中。本发明用中医理论总结，具有健脾和胃，益气生津，养血益肾为主的功效，兼具养肝明目，除湿利尿，清心氨神。尤为显著的实际作用是润肠通便，又止泻收敛的双向作用明确。本发明的特点是将多种中药膳方进行复合组方，形成多变、互补的关系。包含三十余种传统配方，起到了作用相加，一食多功能的作用。
本发明据《中国居民膳食指南》和植物学定义划分为普通食物，据中医理论划分为药膳，具有双重特点。本发明的实际防病保健作用有：调节血糖，降低血脂，减少胆固醇含量，预防动脉粥样硬化，预防心脑血管疾病，预防脂肪肝，增强免疫力，预防癌症，预防便秘，控制体重，抗衰老等作用。
具体实施方式
下面结合实施例对本发明作进一步的详细说明，但并不限制本发明的内容。
本发明食疗养生组合物：
黄豆：黄豆的学名为大豆，含异黄酮，可断绝癌细胞营养供应，含人体必需的8种氨基酸，多种维生素及多种微量元素，可降低血中胆固醇，预防高血压、冠心病、动肪硬化、可以美容等。黄豆内含亚油酸，能促进儿童神经发育。黄豆中不但含胆固醇，并可以降低人体胆固醇，减少动脉硬化的发生，预防心脏病，黄豆中还含有一种抑胰酶的物质，它对糖尿病有一定的疗效。因此，黄豆被营养学家推荐为防治冠心病，高血压动脉粥样硬化等疾病的理想保健品。黄豆中所含的软磷脂的大脑细胞组成的重要部分，常吃黄豆对增加和改善大脑技能有重要的效能。
高粱米：高粱米有一定的药效，具有和胃、健脾、消积、温中、涩肠胃、止霍乱的功效。高粱米中含有单宁，有收敛固脱的作用，患有慢性腹泻的病人常食高粱米粥有明显疗效。
豌豆：其主要功能：补肝养胃、滋补强壮、有助于长筋骨、悦颜面、乌发明目、延年
益寿等功效。每天食用豌豆可以降低血液中的胆固醇。
苦荞米：苦荞米可单独做米饭和粥，也可以掺入到大米和其它杂粮中食用。气味清香，色泽黄绿，柔软可口。长期食用，可防治高血糖，高血压，高血脂，提高免疫力，增强体质。
大麦仁，大麦仁味甘性平，有平胃止渴，消渴除热、益气调胸宽下气、消积进食，补虚劣，壮血脉、益颜色、五脏化谷食之功效；治小便淋痛，治麦芒入目，治老人烦渴不止、饮水不定，舌卷干焦，治水气病，夏季清暑热，治急性咽喉炎、扁桃体炎、咽喉部脓肿
黑小麦，黑小麦可防止癌症，黑小麦中带有的不可溶化学纤维本酚素，大豆异黄酮及其营养元素硒，均具备显著的防癌功效。常常服用黑麦食品可合理减少乳腺癌、前列腺癌和大肠癌等病症的患病率；防衰老。黑麦中带有营养元素硒，可合理消除身体身体氧自由基，减缓机体脆化；降血压降血脂。黑麦中含有可溶黑麦化学纤维，可降低血糖，减少胆固醇，阻拦脂质过氧化瓜，对高血压、高脂血症等病症都是有显著的预防功效；预防肝癌，有研究表明，黑麦面包的构造密不可分而且环境湿度大，在人体内溶解的速率比较慢，要是较少的甘精胰岛素就能维持身体血液的均衡因而常吃黑麦面包能够做到预防肝癌的目地；推动生长发育。黑小麦中带有很多身体不可以自身生成的碳水化合物，在其中磷酸氢钙的成分是麦子成分的1.5倍，针对少年儿童发肓不能缺乏的组氨酸成分也是麦子成分的1.79倍。多服用黑麦以及产品，能够推动青少年儿童身心健康生长发育；保护牙齿健骨。黑小麦中带有的营养元素氟是骨骼和牙的关键成份，常常服用黑小麦及产品可防止龋齿和老人的骨质疏松症等。
谷壳：谷壳的药用功效，谷壳从中医的角度上看，它味甘性平，而且偏于补气，益气健脾和养心安神以及补肾健脑是它的重要功效，平时多用于人类气血不足和脾肾偏亏以及失眠等。
麸皮：有效改善便秘。麸皮中含有丰富的膳食纤维,是人体必需的营养元素。适当食用可提高食物中的纤维成分，可改善大便秘结情况，，同时可促使脂肪及氮的排泄，对临床常见纤维缺乏性疾病具有防治作用，降低体内胆固醇；由于摄入了高纤维成分，从而可以降低粪便中的类固醇的排出，而人体内胆固醇的主要分界代谢过程是通过粪便的排泄，所以使血清胆固醇下降，动脉粥样硬化的形成减慢；润肤润肺乌发疗效；可有助于预防结肠及直肠癌；可降低血液中雌激素的含量，预防乳腺癌；；；可有效促进身体发育成长。麦麸中含有的B族维生素，在体内发挥着许多功能，而且还是食物正常代谢中不可缺少的营养成分。麦麸中的氨基酸含量较高，并且含有丰富的微量元素。这些对儿童的生长发育有很重要的作用。
陈醋：陈醋的主要功效，具有很好的抑菌和杀菌作用，能有效预防肠道疾病、流行性感冒和呼吸疾病，醋软化血管、降低胆固醇，，是高血压等心脑血管疾病患者的一剂良方；醋对皮肤、头发能起到很好的保护作用，中国古代医学就有用醋入药的记载；它有生发、美容、降压、减肥的功效；醋可以消除疲劳，促进睡眠，并能减轻晕车、晕船的不适症状；醋能减少胃肠道和血液中的酒精浓度，起到醒酒的作用；醋的作用可以增强肾功能。
本发明包括由以下重量份的原料制备而成：高梁米0.1～1.0份、豌豆0.01～0.05份、苦荞米0.05～0.1份、大麦仁0.01～0.05份、麸皮0.01～0.05份、水10-30份、陈醋25～40份、黄豆50～70份、黑小麦5～15份、谷壳5-15份。
本发明包括由以下重量份的原料制备而成：高粱米0.5～1.0份、豌豆0.01～0.03份、苦荞米0.075～0.1份、大麦仁0.04～0.05份、麸皮0.01～0.03份、水15-25份、陈醋35～40份、黄豆50～65份、黑小麦8～12份、谷壳8-12份。
本发明包括由以下重量份的原料制备而成：高粱米0.1～0.5份、豌豆0.03～0.05份、苦荞0.05～0.075份、大麦仁0.01～0.04份、麸皮0.03～0.05份、水20份、陈醋25～35份、黄豆65～70份、黑小麦10份、谷壳10份。
本发明包括由以下重量份的原料制备而成：包括由以下重量份的原料制备而成：高粱米0.5份、豌豆0.03份、苦荞米0.075份、大麦仁0.04份、麸皮0.03份、水20份、陈醋35份、黄豆65份、黑小麦10份、谷壳10份。
本发明包括由以下重量份的原料制备而成：包括由以下重量份的原料制备而成：高粱米0.35份、豌豆0.04份、苦荞米0.06份、大麦仁0.03份、麸皮0.03份、水20份、陈醋30份、黄豆60份、黑小麦10份、谷壳10份。
本发明安装如下步骤进行：；按照上述配方称取高粱米、豌豆、大麦仁、麸皮、黑小麦、谷壳和水，具体是先将所述高粱米、豌豆、大麦仁、麸皮、黑小麦、谷壳浸泡在水中25～30min,然后加热蒸煮，沸水条件下蒸煮30～60min得到混合物；按照上述配方称取，然后将苦荞米和黄豆混合在一起，按照普通的磨粉工艺加工成含水量为2～13%、细度为80～200目的细粉；按照上述配方称取陈醋。步骤（1）得到的混合物和步骤（2）得到的细粉混合侵泡在陈醋中，密闭条件下浸泡12～24小时得到产品。
不同病症人群，通过服用--定时间的本发明食疗保健品后，症状均有明显改善,具体效果如下:
用法及用量:每天早餐前睡觉前各5—10g/次
糖尿病患者.
食用1个月后即有效,三个月后效果明显。
高血压患者
食用一个月后即有效,三个月后效果明显。
胃病患者
食用10——15天后即有效,1个月后效果明显。
高血脂患者
轻度血脂稠患者食用7——12后即有效，两个月后效果明显。
根据发明人数代的临床验证，食用本发明食疗保健品后，症状均有明显改善:从2009年--2014年5年间,共收治全国19省市自治区100多个县份的糖尿病患者、高血压患者、高血脂患者和胃病患者总计3589余例，其中男性患者人数2153名，女性患者人数1436名:其中糖尿病患者人数894名，高血压患者1732名，高血脂患者486名，胃病患者477名；其中35--45之间青壮年人891名，占24.8%。45--65岁之间中老年人2140名,占59.6%;其他15.6%。
据统计学统计，3589余患例中痊愈2947例,占82.1%,显效464例,占12.9%,有效178例,占5.0%,无例未效。
下面通过典型案例对本发明的功效做进一步说明：
李女士,59岁，她食疗前低压在9mHg,高压158malHg,连续服用三个月本发明保健品，同时加了老年文艺队，内外同治，效果非常明显，一个月高低压均降至临界点,坚持用药三个月低压保持在82-85mmHg,高压在125-130mmHg,停药后末见反弹。
杨先生,25岁,他上腹部疼痛,恶心、呕吐、腹泻,连续服用两周本发明保健品后，上腹部疼痛感消失，稍微恶心，吃了一个月后疼痛、悲心等症状完全消失，停药后未见复发。
王先生,70岁，他尿多、皮肤乾燥、脱水、极度口渴、虚弱无力,空腹血糖为11-13mmol/L,餐后两小时测血糖为16mmol/L,连续服用一个月本发明保健品后，空腹血糖为6.4-7.3mmo1/L,餐后两小时测血糖为8mmo1/L,持续再服用两个月后空腹血糖为4.4-5.7mmol/L,餐后两小时测血糖为7.4-8.0mol/L,尿多、皮肤乾燥、脱水、极度口渴、虚弱无力等症状消失，停药后未见复发。
宋女士,42岁,她出现头晕目眩、胸闷、心慌,总胆固醇为7.72mmol/L(200mg/dl),连续服用7天本发明保健品后，总胆固醇(TC)为5.72mmol/L(200mg/d1),接着服用本发明保健品一个月后，头晕、胸闷、心慌等症状消失，停药后未见反弹。
李先生,38岁，身高171cm,体重91kg,他出现头晕、神疲乏力、失眠健忘、胸闷、心悸，血浆中血脂的含量为190mg/dL,连续服用9天本发明保健品后，血浆中血脂的含量为150mg/dL,接着服用本发明保健品-一个月后，头晕、神疲乏力、失眠健忘、胸闷、心悸等症状消失，停药后未见反弹。
张女士，65岁，她发热，多汗,口干,寒战，手足震颤，心悸等症状，血压显著增高:收缩压升高可达200mmHg,严重时舒张压也显著增高，可达117mmHg,连续服用三个月本发明保健品，效果非常明显，一个月高低压均降至临界点，坚持用药三个月低压保持在70-85mmHg,高压在120-130mmHg,停药后末见反弹。
陈先生,76岁,研究员,高血压患者,有十多年病史,一直服用西药降压，不服用药时，高压达160-180mmHg,低压85-92mmHg;自从服用本品，中止西药降压，每天早晚各一次，用量5~10g/次，发现血压逐渐降低，但是血压有波动，服用一个月后，期间不服用西药，医院检查结果为130mmHg/80mmHg,恢复到正常范围,现在继续服用,巩固疗效。
Claims (6)
1.提高免疫力、降低三高、润肠通便的养生保健膏，其特征在于：本发明包括由以下重量份的原料制备而成：高梁米0.1～1.0份、豌豆0.01～0.05份、苦荞米0.05～0.1份、大麦仁0.01～0.05份、麸皮0.01～0.05份、水10-30份、陈醋25～40份、黄豆50～70份、黑小麦5～15份、谷壳5-15份。
2.根据权利要求所述的提高免疫力、降低三高、润肠通便的养生保健膏，其特征是：它是由以下重量份的原料制备而成：高粱米0.5～1.0份、豌豆0.01～0.03份、苦荞米0.075～0.1份、大麦仁0.04～0.05份、麸皮0.01～0.03份、水15-25份、陈醋35～40份、黄豆50～65份、黑小麦8～12份、谷壳8-12份。
3.根据权利要求所述的提高免疫力、降低三高、润肠通便的养生保健膏，其特征是：它是包括由以下重量份的原料制备而成：高粱米0.1～0.5份、豌豆0.03～0.05份、苦荞0.05～0.075份、大麦仁0.01～0.04份、麸皮0.03～0.05份、水20份、陈醋25～35份、黄豆65～70份、黑小麦10份、谷壳10份。
4.根据权利要求1所述的提高免疫力、降低三高、润肠通便的养生保健膏，其特征是：它是包括由以下重量份的原料制备而成：包括由以下重量份的原料制备而成：高粱米0.5份、豌豆0.03份、苦荞米0.075份、大麦仁0.04份、麸皮0.03份、水20份、陈醋35份、黄豆65份、黑小麦10份、谷壳10份。
5.根据权利权利要求1所述的提高免疫力、降低三高、润肠通便的养生保健膏，其特征是：它是包括由以下重量份的原料制备而成：包括由以下重量份的原料制备而成：、高粱米0.35份、豌豆0.04份、苦荞米0.06份、大麦仁0.03份、麸皮0.03份、水20份、陈醋30份、黄豆60份、黑小麦10份、谷壳10份。
6.权利权利要求1所述提高免疫力、降低三高、润肠通便的养生保健膏的制备方法，其特征是：按照上述配方称取高粱米、豌豆、大麦仁、麸皮、黑小麦、谷壳和水，具体是先将所述高粱米、豌豆、大麦仁、麸皮、黑小麦、谷壳浸泡在水中25～30min,然后加热蒸煮，沸水条件下蒸煮30～60min得到混合物；按照上述配方称取，然后将苦荞米和黄豆混合在一起，按照普通的磨粉工艺加工成含水量为2～13%、细度为80～200目的细粉；按照上述配方称取陈醋，然后将步骤（1）得到的混合物和步骤（2）得到的细粉混合侵泡在陈醋中，密闭条件下浸泡12～24小时得到产品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110432882.9A CN113057324A (zh) | 2021-04-21 | 2021-04-21 | 提高免疫力、降低三高、润肠通便的养生保健膏 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110432882.9A CN113057324A (zh) | 2021-04-21 | 2021-04-21 | 提高免疫力、降低三高、润肠通便的养生保健膏 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113057324A true CN113057324A (zh) | 2021-07-02 |
Family
ID=76567338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110432882.9A Pending CN113057324A (zh) | 2021-04-21 | 2021-04-21 | 提高免疫力、降低三高、润肠通便的养生保健膏 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113057324A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637255A (zh) * | 2009-08-19 | 2010-02-03 | 王寿光 | 一种降糖营养粉 |
| CN104207121A (zh) * | 2014-07-07 | 2014-12-17 | 郑州乐嫒商贸有限公司 | 一种提高免疫力降低三高的食疗保健品 |
| CN106616283A (zh) * | 2016-12-27 | 2017-05-10 | 许新升 | 降三高营养粉及其制备方法 |
| CN112137098A (zh) * | 2020-10-22 | 2020-12-29 | 郭小卫 | 一种大众健康早餐粉及其制备方法 |
-
2021
- 2021-04-21 CN CN202110432882.9A patent/CN113057324A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637255A (zh) * | 2009-08-19 | 2010-02-03 | 王寿光 | 一种降糖营养粉 |
| CN104207121A (zh) * | 2014-07-07 | 2014-12-17 | 郑州乐嫒商贸有限公司 | 一种提高免疫力降低三高的食疗保健品 |
| CN106616283A (zh) * | 2016-12-27 | 2017-05-10 | 许新升 | 降三高营养粉及其制备方法 |
| CN112137098A (zh) * | 2020-10-22 | 2020-12-29 | 郭小卫 | 一种大众健康早餐粉及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107173694A (zh) | 一种营养全面平衡的全素食代餐粉配方 | |
| CN106261763A (zh) | 一种谷物膳食纤维代餐粉及其制备方法 | |
| CN102934759A (zh) | 一种改善奶质的奶牛饲料 | |
| CN109966417A (zh) | 一种针对糖尿病人群的固体饮料 | |
| CN104855802A (zh) | 一种食疗营养粥粉及其制备方法 | |
| CN109549097A (zh) | 一种具有降糖降脂功能的保健面条 | |
| CN109497227A (zh) | 一种红糖杞枣保健姜茶 | |
| CN106418501A (zh) | 一种具有减肥功能的保健食品 | |
| CN102090563A (zh) | 一种纾压和舒眠的保健食品及其制备方法 | |
| KR20130063074A (ko) | 당뇨병과 당뇨합병증의 혈당 혈압 저하작용 조성물 | |
| CN1698875A (zh) | 一种治疗癌症的药酒 | |
| CN105249440A (zh) | 一种阿胶糕 | |
| KR100742502B1 (ko) | 아토피 치료 한방 조성물 | |
| CN112155159A (zh) | 一种健康面粉的制备方法 | |
| CN101912115A (zh) | 一种改善睡眠的营养米及其加工方法 | |
| CN104323391A (zh) | 一种植物保健固体饮料及其制备方法 | |
| CN106418143A (zh) | 一种改善睡眠和视力的组合物及其用途 | |
| CN110638038A (zh) | 一种用于控制高血糖的医学配方营养代餐粉及其制备方法 | |
| CN109007573A (zh) | 一种调节亚健康的五谷类养生代餐粉及其加工工艺 | |
| CN105559076B (zh) | 一种备孕期男性全营养药膳餐糊 | |
| CN104207121B (zh) | 一种提高免疫力降低三高的食疗保健品 | |
| CN113057324A (zh) | 提高免疫力、降低三高、润肠通便的养生保健膏 | |
| CN102552743A (zh) | 一种用于治疗糖尿病的药物组合物及其制备方法 | |
| CN111700949A (zh) | 一种提高免疫能力的中药 | |
| CN112137098A (zh) | 一种大众健康早餐粉及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210702 |